Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BlackRock Inc. NVRI Enviri Corp 13G/A 18.4% 2y
BlackRock Inc. YELP Yelp Inc 13G/A 18.1% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC FRBN Forbion European Acquisition Corp. Class A Ordinary Shares 13G/A 0% 2y
BlackRock Inc. WNC WABASH NATIONAL Corp 13G/A 17.4% 2y
BlackRock Inc. SANM Sanmina Corp 13G/A 19.3% 2y
Millennium Management LLC HARP Harpoon Therapeutics, Inc. Common Stock 13G/A 0.2% 2y
BlackRock Inc. HPP Hudson Pacific Properties, Inc. 13G/A 19.6% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC DSAQ Direct Selling Acquisition Corp. 13G/A 0% 2y
BlackRock Inc. SKT Tanger Inc. 13G/A 18.3% 2y
BlackRock Inc. PLUS Eplus Inc 13G/A 17.9% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares 13G/A 0% 2y
BlackRock Inc. LTC Ltc Properties Inc 13G/A 18.4% 2y
BlackRock Inc. CSR Centerspace 13G/A 19% 2y
HIGHBRIDGE CAPITAL MANAGEMENT LLC ALOR ALSP Orchid Acquisition Corporation I Class A Ordinary Share 13G/A 0% 2y
BlackRock Inc. ATEN A10 Networks, Inc. 13G/A 17.8% 2y
BlackRock Inc. SPTN SpartanNash Company 13G/A 18.5% 2y
Frontier Disruption Capital FICV Frontier Investment Corp Class A Ordinary Shares 13D/A 64.65% 2y
F9 Investments, LLC (Single Member LLC with Thomas D. Sullivan Single Member) LL LL Flooring Holdings, Inc. 13D/A 8.8% 2y
Fund 1 Investments, LLC BJRI BJs RESTAURANTS INC 13D 9.5% 2y
Cove Street Capital, LLC DLHC DLH Holdings Corp. 13G/A 4.35% 2y
Larry A. Mizel MDC M.D.C. Holdings, Inc. 13D/A 13.2% 2y
David D. Mandarich MDC M.D.C. Holdings, Inc. 13D/A 8% 2y
Vodafone Ventures Ltd ASTS AST SpaceMobile, Inc. 13D/A 10.1% 2y
Saba Capital Management, L.P. ECAT BlackRock ESG Capital Allocation Term Trust 13D/A 24.05% 2y
Saba Capital Management, L.P. NMAI Nuveen Multi-Asset Income Fund 13D/A 14.12% 2y
Saba Capital Management, L.P. JRI Nuveen Real Asset Income & Growth Fund 13D/A 9.11% 2y
Saba Capital Management, L.P. NPCT Nuveen Core Plus Impact Fund 13D/A 10.36% 2y
Oaktree Capital Holdings, LLC TRMD TORM plc 13D/A 57.33% 2y
Liberty 77 Capital L.P. STRZ Starz Entertainment Corp 13D/A 7.9% 2y
OH Cypress Aggregator, L.P. CCC CCC Intelligent Solutions Holdings Inc. 13D/A 8.8% 2y
BIOTECHNOLOGY VALUE FUND L P ALLK Allakos Inc. 13G/A 18.9% 2y
Silver Lake Group, L.L.C. DELL Dell Technologies Inc. 13D/A 24.1% 2y
Saba Capital Management, L.P. MMU Western Asset Managed Municipals Fund Inc. 13G 5.14% 2y
Luxor Capital Group, LP AAMC Altisource Asset Mgmt Corp 13D/A 0% 2y
Sculptor Capital LP LCAA L Catterton Asia Acquisition Corp Class A Ordinary Shares 13G 7% 2y
Saba Capital Management, L.P. NPFD Nuveen Variable Rate Preferred & Income Fund 13D 5.62% 2y
BIOTECHNOLOGY VALUE FUND L P IMUX Immunic, Inc. 13G 9.9% 2y
JANUS HENDERSON GROUP PLC IMUX Immunic, Inc. 13G 7.4% 2y
Millennium Management LLC NTST NETSTREIT Corp. 13G 5.7% 2y
BOXER CAPITAL, LLC NKTX Nkarta, Inc. 13G 9% 2y
MERCK & CO., INC. PAND Pandion Therapeutics Inc. Common Stock 13D 17.48% 2y
Richard M. Brooks ZUMZ Zumiez Inc 13G/A 13.35% 2y
Deborah S. Harrison (Deborah H. Everhart)* COKE Coca-Cola Consolidated, Inc. 13G/A 3.4% 2y
FEDERATED HERMES, INC. NERV Minerva Neurosciences, Inc. 13G/A 19.32% 2y
Dapice Joshua J. ARYD ARYA Sciences Acquisition Corp IV Class A Odinary Shares 13G/A 4.8% 2y
TOMS Capital Investment Management LP DISA Disruptive Acquisition Corporation I Class A Ordinary Shares 13G 64.7% 2y
POLEN CAPITAL MANAGEMENT LLC FET Forum Energy Technologies, Inc. 13G/A 0% 2y
BIOTECHNOLOGY VALUE FUND L P ALLK Allakos Inc. 13G/A 9.8% 2y
FEDERATED HERMES, INC. SSTI Soundthinking, Inc. 13G/A 10.34% 2y
Thomas D. Campion ZUMZ Zumiez Inc 13G/A 5.1% 2y